11
TITLE: RNA Interference Applications for Machado-Joseph Disease
AUTHORS: José M. Codêsso; Carlos A. Matos; Clévio Nóbrega;
PUBLISHED: 2023, SOURCE: RNA Therapeutics - History, Design, Manufacturing, and Applications
INDEXED IN: CrossRef
IN MY: ORCID
12
TITLE: p ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease
AUTHORS: Vasconcelos Ferreira, A; Martins, IM; Lobo, D; Pereira, D; Lopes, MM; Faro, R; Lopes, SM; Verbeek, D; Schmidt, T; Nobrega, C; de Almeida, LP ;
PUBLISHED: 2022, SOURCE: MOLECULAR THERAPY, VOLUME: 30, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 10
IN MY: ORCID
13
TITLE: MUTANT ATAXIN-2 PATHOLOGICAL FEATURES IS ALTERED BY THE AGING PROCESS  Full Text
AUTHORS: Afonso, Ines Torquato; Lima, Patricia; Matos, Carlos A.; Nobrega, Clevio;
PUBLISHED: 2022, SOURCE: MEDICINE, VOLUME: 101, ISSUE: 30
INDEXED IN: WOS
14
TITLE: Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
AUTHORS: Afonso, Ines T.; Lima, Patricia; Conceicao, Andre; Matos, Carlos A.; Nobrega, Clevio;
PUBLISHED: 2022, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 23, ISSUE: 19
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
15
TITLE: The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits
AUTHORS: Koppenol, Rebekah; Conceicao, Andre; Afonso, Ines T.; Afonso Reis, Ricardo; Costa, Rafael G.; Tome, Sandra; Teixeira, Diogo; da Silva, Joana Pinto; Codesso, Jose Miguel; Brito, David V. C.; Mendonca, Liliana; Marcelo, Adriana; de Almeida, Luis Pereira ; Matos, Carlos A.; Nobrega, Clevio;
PUBLISHED: 2022, SOURCE: BRAIN, VOLUME: 146, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 12
IN MY: ORCID
16
TITLE: Autophagy is dysregulated in spinocerebellar ataxia type 2
AUTHORS: Adriana Marcelo; Carlos A Matos; Clévio Nóbrega;
PUBLISHED: 2022, SOURCE: Autophagy Reports, VOLUME: 1, ISSUE: 1
INDEXED IN: CrossRef
IN MY: ORCID
17
TITLE: MITIGATING THE PROGEROID PHENOTYPE: A GENE DELIVERY STRATEGY TO IMPROVE PROGERIN-ASSOCIATED ABNORMALITIES  Full Text
AUTHORS: Costa, RG; Aveleira, C; Nobrega, C;
PUBLISHED: 2021, SOURCE: 24th Annual Meeting of the Portuguese-Society-of-Human-Genetics (SPGH) in MEDICINE, VOLUME: 100, ISSUE: 4
INDEXED IN: WOS
18
TITLE: Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
AUTHORS: Afonso Reis, R; Afonso, IT; Nobrega, C;
PUBLISHED: 2021, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 22, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 15
IN MY: ORCID
19
TITLE: Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?
AUTHORS: Marcelo, A; Koppenol, R; de Almeida, LP ; Matos, CA; Nobrega, C;
PUBLISHED: 2021, SOURCE: CELL DEATH & DISEASE, VOLUME: 12, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 94
IN MY: ORCID
20
TITLE: The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease  Full Text
AUTHORS: Vasconcelos Ferreira, A; Carmo Silva, S; Codesso, JM; Silva, P; Martinez, ARM; Franca, MC; Nobrega, C; de Almeida, LP ;
PUBLISHED: 2021, SOURCE: Neuropathology and Applied Neurobiology in NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, VOLUME: 48, ISSUE: 1
INDEXED IN: WOS CrossRef: 17 Handle
IN MY: ORCID
Page 2 of 10. Total results: 95.